Delivery Order SPE2DB24D2013-SPE2DB24FCGSP
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,043.90 Firm Fixed Price Delivery Order is for the supply of the drug product Cosentyx (300 mg dose, 2 pens per milliliter) to the DLA. The contract has a period of performance through June 12, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of pharmaceutical products, specifically the medication Cosentyx, to the Department of Defense (DoD) and its Medical Supply Chain. The contract, valued at $2,008.73, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,043.90. The contract is for the supply of Cosentyx, a prescription medication, with a period of performance through May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract, valued at $3,043.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,776.63 firm-fixed-price delivery order is for the supply of Cosentyx Unoready 300 mg pen, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,702.06, is a Firm Fixed Price Delivery Order for the supply of the medication Cosentyx. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,836.39 firm fixed-price delivery order is for the supply of Cosentyx 300 mg dose-2 syringes. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of Cosentyx Unoready 300 mg pen (2 ml) to the DLA Troop Support Medical program, which supports the Department of Defense. The contract has a ceiling value of $9,131.70 and a period of performance through April 30, 2024....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Cosentyx, a specialty medication. The $3,149.12 firm-fixed-price delivery order has a completion date of December 3, 2024 and is not associated with any set-aside requirements. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB24FCGSPDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,521.95, is for the delivery of the pharmaceutical product Cosentyx Unoready 300 mg Pen 2 ml. This is a firm-fixed price delivery order contract with a completion date of May 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/23/24 |